Lysophosphatidylcholine up-regulates CXCR4 chemokine receptor expression in human CD4 T cells

Journal of Leukocyte Biology

Volumn 76, Issue 1, 2004, Pages 195-202

  Han, Ki Hoon ^a   Hong, Kyung Hee ^a   Ko, Jesang ^a   Rhee, Kyong Suk ^a   Hong, Myeong Ki ^a   Kim, Jae Joong ^a   Kim, You Ho ^a   Park, Seung Jung ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

Atherosclerosis; CD4; CD4 T cells; CXCR4; Lysophosphatidyl choline; SDF 1

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; CAFFEIC ACID PHENETHYL ESTER; CD3 ANTIBODY; CD3 ANTIGEN; CD4 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; CYTOKINE ANTIBODY; G PROTEIN COUPLED RECEPTOR; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN G; INTERLEUKIN 2; LOW DENSITY LIPOPROTEIN; LYSOPHOSPHATIDYLCHOLINE; PROTEIN G2A; STROMAL CELL DERIVED FACTOR 1; UNCLASSIFIED DRUG;

ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CHEMOTAXIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; HUMAN; HUMAN CELL; INFLAMMATION; LIPID OXIDATION; PRIORITY JOURNAL; PROTEIN FUNCTION; T LYMPHOCYTE; UPREGULATION;

ARTERIOSCLEROSIS; CD4-POSITIVE T-LYMPHOCYTES; CELL CYCLE PROTEINS; CHEMOKINES; CHEMOKINES, CXC; CHEMOTAXIS, LEUKOCYTE; DOSE-RESPONSE RELATIONSHIP, DRUG; FLOW CYTOMETRY; HUMANS; LYSOPHOSPHATIDYLCHOLINES; NF-KAPPA B; POLYMERASE CHAIN REACTION; RECEPTORS, CXCR4; RECEPTORS, G-PROTEIN-COUPLED; TIME FACTORS; UP-REGULATION;

EID: 3042743358     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.1103563     Document Type: Article

References (43)

1. Glass, C. K., Witztum, J. L. (2001) Atherosclerosis: the road ahead. Cell 104, 503-516.
2. Hansson, G. K., Jonasson, L., Seifert, P. S., Stemme, S. (1989) Immune mechanisms in atherosclerosis. Arteriosclerosis 9, 567-578.
3. Hansson, G. K. Regulations of immune mechanisms in atherosclerosis. (2001) Ann. N. Y. Acad. Sci. 947, 157-166.
4. Benagiano, M., Azzurri, A., Ciervo, A., Amedei, A., Tamburini, C., Ferrari, M., Telford, J. L., Baldari, C. T., Romagnani, S., Cassone, A., D'Elios, M. M., Del Prete, G. (2003) T helper type 1 lymphocytes drive inflammation in human atherosclerotic lesions. Proc. Natl. Acad. Sci. USA 100, 6658-6663.
5. Gupta, S., Pablo, A. M., Jiang, X-C., Wang, N., Tall, A. R., Schindler, C. (1997) IFN-γ potentiates atherosclerosis in apoE knock-out mice. J. Clin. Invest. 99, 2752-2561.
6. Whitman, S. C., Ravisankar, P., Elam, H., Daugherty, A. (2000) Exogenous interferon-γ enhances atherosclerosis in apolipoprotein E-/- mice. Am. J. Pathol. 157, 1819-1824.
7. Stemme, S., Holm, J., Hansson, G. K. (1992) T lymphocytes in human atherosclerotic plaques are memory cells expressing CD45RO and the integrin VLA-1. Arterioscler. Throm. 12, 206-211.
8. Sakata-Kaneko, S., Wakatsuki, Y., Ushi, T., Matsunaga, Y., Itoh, T., Nishii, E., Kume, N., Kita, T. (1998) Lysophosphatidylcholine upregulates CD40 ligand expression in newly activated human CD4+ T cells. FEBS Lett. 433, 161-165.
9. Nishi, E., Kume, N., Ueno, Y., Ochi, H., Moriwaki, H., Kita, T. (1998) Lysophosphatidylcholine enhances cytokine-induced interferon γ expression in human T lymphocytes. Circ. Res. 83, 508-515.
10. Abi-Younes, S., Sauty, A., Mach, F., Sukhova, G. K., Libby, P., Luster, A. D. (2000) The stromal cell-derived factor-1 chemokine is a potent platelet agonist highly expressed in atherosclerotic plaques. Circ. Res. 86, 131-138.
11. Bleul, C. C., Fuhlbrigge, B. C., Casanovas, J. M., Aiuti, A., Springer, T. A. (1996) A highly efficacious lymphocyte chemoattractant, stromal derived factor-1 (SDF-1). J. Exp. Med. 184, 1101-1109.
12. Nanki, T. Lipsky, P. E. (2000) Cutting edge: stromal-cell derived factor-1 is a costimulator for CD4+ T cell activation. J. Immunol. 164, 5010-5014.
13. Harvel, R. J., Eder, H. A., Bragdon, J. H. (1955) The distribution and chemical composition of ultracentrifugally seperated lipoproteins in human serum. J. Clin. Invest. 34, 1345-1353.
14. Conti, M., Morad, P. C., Levillian, P., Lemonnier, A. (1991) Improved fluorometric determination of malonaldehyde. Clin. Chem. 37, 1273-1275.
15. Chomczynski, P., Sacchi, N. (1987) Single step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156-159.
16. Han, K. H., Han, K. O., Green, S. R., Quehenberger, O. (1999) Expression of monocyte chemoattractant protein-1 receptor CCR2 is increased in hypercholesterolemia. Different effects of plasma lipoproteins on monocyte function. J. Lipid. Res. 40, 1053-1063.
17. Gupta, S. K., Pillarisetti, K., Lysko, P. G. (1999) Modulation of CXCR4 expression and SDF-1α functional activity during differentiation of human monocytes and macrophages. J. Leukoc. Biol. 66, 135-143.
18. Kabarowski, J. H., Zhu, K., Le, L. Q., Witte, O. N., Xu, Y. (2001) Lysophosphatidylcholine as a ligand for the immunoregulatory receptor G2A. Science 293, 702-705.
19. Palinski, W., Rosenfeld, M. E., Yla-Herttuala, S., Gurtner, G. C., Socher, S. S., Butler, S., Parthasarathy, S., Carew, T. E., Steinberg, D., Witztum, J. L. (1989) Low density lipoprotein undergoes oxidative modifications in vivo. N. Engl. J. Med. 320, 915-924.
20. Ross, R., The pathogenesis of atherosclerosis: a perspective for the 1990s. (1993) Nature 362, 801-809.
21. Steinbrecher, U. P., Pritchard, P. H. (1989) Hydrolysis of phosphatidylcholine during LDL oxidation is mediated by platelet-activating factor acetylhydrolase. J. Lipid. Res. 30, 305-315.
22. Steinbrecher, U. P., Parthasarathy, S., Leake, D. S., Witztum, J. L., Steinberg, D. (1984) Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc. Natl. Acad. Sci. USA 81, 3883-3887.
23. Packard, C. J., O'Reilly, D. S., Caslake, M. J., McMahon, A. D., Ford, I., Cooney, J., Macphee, C. H., Suckling, K. E., Krishna, M., Wilkinson, F. E., Rumley, A., Lowe, G. D. (2000) Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease: West of Scotland Coronary Prevention Study Group. N. Engl. J. Med. 343, 1148-1155.
24. Parthasarathy, S., Steinbrecher, U. P., Barnett, J., Witztum, J. L., Steinberg, D. (1985) Essential role of phospholipase A2 activity in endothelial cell-induced modification of low density lipoprotein. Proc. Natl. Acad. Sci. USA 82, 3000-3004.
25. Subbanagounder, G., Leitinger, N., Schwenke, D. C., Wong, J. W., Lee, H., Rizza, C., Watson, A. D., Faull, K. F., Fogelman, A. M., Berliner, J. A. (2000) Determinants of bioactivity of oxidized phospholipids. Specific oxidized fatty acyl groups at the sn-2 position. Arterioscler. Thromb. Vasc. Biol. 20, 2248-2254.
26. Kabarowski, J. H., Xu, Y., Witte, O. N. (2002) Lysophosphatidylcholine as a ligand for immunoregulation. Biochem. Pharmacol. 64, 161-167.
27. Weng, Z., Fluckiger, A. C., Nisitani, S., Wahl, M. I., Le, L. Q., Hunter, C. A., Fernal, A. A., Le Beau, M. M., Witte, O. N. (1998) A DNA damage and stress inducible G protein-coupled receptor blocks cells in G2/M. Proc. Natl. Acad. Sci. USA 95, 12334-12339.
28. Kabarowski, J. H., Feramisco, J. D., Le, L. Q., Gu, J. L., Luoh, S. W., Simon, M. I., Witte, O. N. (2000) Direct genetic demonstration of Gα13 coupling to the orphan G protein-coupled receptor G2A leading to RhoA-dependent actin rearrangement. Proc. Natl. Acad. Sci. USA 97, 12109-12114.
29. Zohn, I. E., Klinger, M., Karp, X., Kirk, H., Chrzanowska-Wodnicka, M., Der, C. J., Kay, R. J. (2000) G2A is an oncogenic G protein-coupled receptor. Oncogene 19, 3866-3877.
30. Lin, P., Ye, R. D. (2003) The lysophospholipid receptor G2A activates a specific combination of G proteins and promotes apoptosis. J. Biol. Chem. 278, 14379-14386.
31. Han, C. Y., Park, S. Y., Pak, Y. K. (2000) Role of endocytosis in the transactivation of nuclear factor-κB by oxidized low-density lipoprotein. Biochem. J. 350, 829-837.
32. Ottoson, N. C., Pribila, J. T., Chan, A. S. H., Shimizu, Y. (2001) Cutting edge: T cell migration regulated by CXCR4 chemokine receptor signaling to ZAP-70 tyrosine kinase. J. Immunol. 167, 1857-1861.
33. Wang, J., Guan, E., Roderiquez, G., Calvert, V., Alvarez, R., Norcross, M. A. (2001) Role of tyrosine phosphorylation in ligand-independent sequestration of CXCR4 in human primary monocytes-macrophages. J. Biol. Chem. 276, 49236-49243.
34. Portman, O. W., Alexander, M. (1969) Lysophosphatidylcholine concentrations and metabolism in aortic intima plus inner media: effect of nutritionally induced atherosclerosis. J. Lipid. Res. 10, 158-165.
35. Yla-Herttuala, S., Palinski, W., Rosenfeld, M. E., Parthasarathy, S., Carew, T. E., Butler S., Witztum, J. L., Steinberg, D. (1989) Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J. Clin. Invest. 84, 1086-1095.
36. Quinn, M. T., Parthasarathy, S., Steinberg, D. (1988) Lysophosphatidylcholine: a chemotactic factor for human monocytes and its potential role in atherogenesis. Proc. Natl. Acad. Sci. USA 85, 2805-2809.
37. McMurray, H. F., Parthasarathy, S., Steinberg, D. (1993) Oxidatively modified low density lipoprotein is a chemoattractant for human T lymphocytes. J. Clin. Invest. 92, 1004-1008.
38. Nakano, T., Raines, E. W., Abraham, J. A., Klagsbrun, M., Ross, R. (1994) Lysophosphatidylcholine upregulates the level of heparin-binding epidermal growth factor-like growth factor mRNA in human monocytes. Proc. Natl. Acad. Sci. USA 91, 1069-1073.
39. Sakai, M., Miyazaki, A., Hakamata, H., Sasaki, T., Yui, S., Yamazaki, M., Shichiri, M., Horiuchi, S. (1994) Lysophosphatidylcholine plays an essential role in the mitogenic effect of oxidized low density lipoprotein on murine macrophages. J. Biol. Chem. 269, 31430-31435.
40. Kugiyama, K., Kerns, S. A., Morrisett, J. D., Roberts, R., Henry, P. D. (1990) Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins. Nature 344, 160-162.
41. Kume, N., Cybulsky, M. I., Gimbrone Jr., M. A. (1992) Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells. J. Clin. Invest. 90, 1138-1144.
42. Kume, N., Gimbrone Jr., M. A. (1994) Lysophosphatidylcholine transcriptionally induces growth factor gene expression in cultured human endothelial cells. J. Clin. Invest. 93, 907-911.
43. Jonasson, L., Holm, J., Skalli, O., Bondjers, G., Hansson, G. K. (1986) Regional accumulation of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque. Arteriosclerosis 6, 131-138.